Is TRIGYN.NS overvalued or undervalued?

TRIGYN.NS currently has a P/E ratio of 15.59. Relative to the sector average of 39.20, this suggests the stock may be undervalued. A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

How can I buy Trigyn Technologies Limited stock?

Trigyn Technologies Limited trades on NSE. Investors in Latin America can buy it through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

Can I buy fractional shares of TRIGYN.NS?

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Does buying TRIGYN.NS protect my money against local inflation?

Many investors in Latin America buy international stocks like TRIGYN.NS to protect their purchasing power. Because TRIGYN.NS is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Do I need a foreign bank account or a Visa to buy TRIGYN.NS shares?

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Is TRIGYN.NS a suitable investment for my portfolio?

There is no universal answer, since fit depends on your situation, not just the stock. Think about three things: how well TRIGYN.NS diversifies what you already own, whether you can stomach its price swings given your risk tolerance, and how long you plan to stay invested. As a rule, a single stock works best as one piece of a broader asset allocation and with a multi-year time horizon. This is general information, not personalized financial advice.

All stocksTRIGYN.NS

Trigyn Technologies Limited

₹51.55-₹0.04-0.08%

NSE / INR

Market cap

₹1.6B

P/E

15.6

EPS (TTM)

₹0.04

Dividend yield

0.00%

Beta

0.90

1Y return

-35.40%

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Compare, tap a companyup to 2 at once

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Financials

The numbers behind the company

Revenue vs net income

RevenueNet income

$137M2022

$155M2023

$153M2024

$105M2025

$104M2026

Financial health

Gross margin

Operating margin

ROE

ROA

Debt to equity0.01Low
Current ratio4.66
Cash ratio2.79
Net margin1.0%
Free cash flow—

Valuation

Is it expensive right now

P/E vs the market

scale 0–50

0153050

TRIGYN.NS15.6
Technology sector median39.2
S&P 50022.0

Trades about 60% below its sector, cheaper than its peers on earnings.

Ratios

PEG0.01
Price to book0.20
EPS (TTM)₹0.04
Payout ratio0%
FCF yield3.37%

Range & risk

₹37.55₹82.00

Trading in the lower third of its 52-week band

Beta0.90

Profile

What Trigyn Technologies Limited actually does

Trigyn Technologies Limited, established in Mumbai, India, in 1986, operates as an international provider of communication and information technology staffing alongside extensive support services. The company delivers a comprehensive array of system integration solutions, covering custom application development and maintenance, enterprise content management, legacy system modernization, mobile application creation, business intelligence and reporting, user experience design and consulting, independent testing, business process outsourcing, and helpdesk assistance. Additionally, Trigyn offers managed services and staff augmentation, supplying expertise in areas such as project and business analysis, network and infrastructure design and support, ERP solutions (both technical and functional), UX/UI, architecture, development, and quality assurance. Their offerings also include general development and maintenance, SAP implementations, and diverse IT solutions. Trigyn serves a broad client base, including international organizations, non-governmental entities, state and local governments, and commercial enterprises across sectors like financial services, pharmaceuticals, manufacturing, and distribution. The company was formerly known as Leading Edge Systems Ltd, changing its name to Trigyn Technologies Limited in July 2000.

CEO

Bhavana Rao Potluri

Employees

744

Headquarters

Mumbai, MA

Founded

2002-07-01

Company website

If you had invested a decade ago

Loading the full price history…

Run your own numbers

Past performance is not a forecast.

ETFs

Own it inside an ETF instead

Vanguard S&P 500

Vanguard Total Stock Market

Vanguard Total World Stock

Invesco QQQ

SPDR S&P 500

iShares Russell 2000

Community sentiment

Bullish—

Distribution

Bearish0%
Neutral0%
Bullish0%

Track it without buyingTrack it

no account needed

Save TRIGYN.NS and get told when something moves.

Get updates

A clear, direct weekly summary.

Keep looking

Q&A

Questions people ask

TRIGYN.NS has a beta of 0.90, which indicates how sensitive it has historically been to movements in its broader market. A beta below 1 indicates lower relative volatility than the market. Beta is based on historical data and does not predict future performance.

Trigyn Technologies Limited